BCL2 and prostate carcinoma: Similar mechanisms targeting Bcl2 and Bax, upregulating caspase-3 pro-apoptotic gene and increasing ROS to further induce apoptosis, were noted, indicating a method to combat the proliferation of prostate cancer [147].